Specialty
Certifications
Neurological Surgery
Clinical Focus
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Acromegaly
- Astrocytoma
- Brain Tumor And Brain Cancer
- Brain, Spine Tumors
- Cerebrospinal Fluid Leak
- Chiari Malformation
- Chondrosarcoma
- Chordoma
- Craniopharyngioma
- Craniotomy
- Hemifacial Spasm
- Meningioma
- Pituitary Adenoma
- Skull Base Tumor/Cancer
- Trigeminal Neuralgia
Education
MD, University of Pennsylvania
B.S, M.S., Stanford University
NeuroscienceInternship, Surgery (General)
Mount Sinai HospitalResidency, Neurosurgery
Mount Sinai HospitalFellowship, Skull Base Surgery
St. Luke's-Roosevelt Hospital Center
Biography
- Dr. Shrivastava specializes in the diagnosis and treatment of skull base tumors, meningiomas and pituitary tumors. He has sub-specialty fellowship training in complex skull base surgery that entails the use of minimally invasive technologies. These consist of endoscopic, 3D and stereotactic navigation in order to safely remove difficult and "hard-to-reach" brain tumors. He has been active in the advancement and development of these technologies through clinical research which has resulted in several national peer-reviewed publications and awards. Dr. Shrivastava lectures nationally and internationally where he has been invited as a guest Professor and Lecturer. He has also been active in the North American Skull Base Society where he has worked on the Scientific Advisory Board. He has been appointed to the Editorial Board of Neurosurgery Journals in the sub-specialty area of skull base and endoscopic surgery.
Most importantly, however, Dr. Shrivastava believes that patient-centered care, good clinical outcome and personalized treatment comes first, this will always be the first priority.
Awards
2012 - 2013
Castle Connolly Top Doctors
Castle Connolly2011 - 2013
US News and World Report Selected Top Doctor-Neurosurgery
2009 - 2013
Compassionate Physician Award - National Award
Patient's Choice - Vital Health Care Group2009 - 2013
America's Top Surgeon Award
Consumer Research Council of America2008 - 2013
Patient's Choice Award - National Award
Patient's Choice - Vital Health Care Group2001 - 2001
American Association of Neurosurgeons (AANS) Vesalius Award - First Presentation
Research
Endoscopic Skull Base Surgery
Our group focuses on the clinical implementation of stereotactic and 3D navigation for minimally invasive skull base and pituitary tumor surgery. We are researching unique visual-evoked-potential (VEP) neuro-physiological monitoring to monitor visual pathways during neurosurgical tumor surgery to provide for improved clinical outcome.Publications
.;.
Tabaee A, Kamat A, Shrivastava R, Buchbinder D. Surgical management of pneumosinus dilatans frontalis in the setting of chronic rhinosinusitis and type III frontal Cell. The Journal of craniofacial surgery 2012 Jan; 23(1).
Shrivastava RK, Arginteanu MS, King WA, Post KD. Giant prolactinomas: clinical management and long-term follow up. Journal of neurosurgery 2002 Aug; 97(2).
Sen C, Triana AI, Berglind N, Godbold J, Shrivastava RK. Clival chordomas: clinical management, results, and complications in 71 patients. Journal of neurosurgery 2010 Nov; 113(5).
Shrivastava RK, Sen C, Costantino P. Surgical approaches to the craniocervical junction for the resection of chordomas. Clinical neurosurgery 2005; 52.
Shrivastava RK, Epstein FJ, Perin NI, Post KD, Jallo GI. Intramedullary spinal cord tumors in patients older than 50 years of age: management and outcome analysis. Journal of neurosurgery. Spine 2005 Mar; 2(3).
Sen C, Shrivastava R, Anwar S, Triana A. Lateral transcondylar approach for tumors at the anterior aspect of the craniovertebral junction. Neurosurgery 2010 Mar; 66(3 Suppl).
Gologorsky Y, Shrivastava RK, Panov F, Mascitelli J, Signore AD, Govindaraj S, Smethurst M, Bronster DJ. Primary intraosseous cavernous hemangioma of the clivus: case report and review of the literature. Journal of neurological surgery reports 2013 Jun; 74(1).
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Shrivastava did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 8 Room 35
1468 Madison Avenue
New York, NY 10029
Fax: 212-241-3252
5 E. 98th Street
7th Floor
New York, NY 10029
Fax: 212-241-3252
- Spanish
- Call Office to Inquire
- Medicaid
- Medicare
- Master Card
- Visa
- American Express
- Discover
- Personal Check
- Cash
- Credit Card (Other)